Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Understanding the mechanisms underlying the progression of chronic obstructive pulmonary disease to lung cancer
FY 2019-20
Summary
"Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease that damages the cells in a patient's airway. Developing COPD increases a person's risk of lung cancer by a factor of two to four, regardless of whether they smoke. The reasons for the increased lung cancer risk of COPD patients are not well understood, and as a result, prevention is difficult. In addition, while immunotherapy is a promising new class of cancer treatments, the roles of immune cells have not been well studied in the context of COPD. Past work in our lab has shown that COPD patients have characteristic changes in the DNA of their airway cells. In particular, we have found that alterations to two genes, PLK4 and p53, are common in both COPD airway cells and lung tumours. Our hypothesis is that these changes vary with COPD severity and, along with the inflammation caused by COPD, promote the onset of lung cancer. To test this hypothesis, we will look at the frequency of PLK4 and p53 alterations in lung tumours in comparison to healthy lung tissue, and investigate whether these changes work together to promote the development of cancer-like traits in lung cell models. We will then determine if these modifications increase the rate of DNA damage over time, which could also heighten cancer risk. Finally, we will use gene activity data to identify the prevalence of different types of immune cells in COPD patient airways, and determine if they are associated with COPD severity. Overall, this project will improve our understanding of the factors that put COPD patients at high risk for lung cancer and provide insight into methods of cancer prevention. It will also expand our knowledge of the role that immune cells play in cancer onset and may contribute to improvements in immunotherapy."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428758
Name
Cohn David
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the mechanisms underlying the progression of chronic obstructive pulmonary disease to lung cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Obstructive Pulmonary Disease; Lung Cancer; P53; Plk4; Tumour Microenvironment; Tumourigenesis
Abstract
"Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease that damages the cells in a patient's airway. Developing COPD increases a person's risk of lung cancer by a factor of two to four, regardless of whether they smoke. The reasons for the increased lung cancer risk of COPD patients are not well understood, and as a result, prevention is difficult. In addition, while immunotherapy is a promising new class of cancer treatments, the roles of immune cells have not been well studied in the context of COPD. Past work in our lab has shown that COPD patients have characteristic changes in the DNA of their airway cells. In particular, we have found that alterations to two genes, PLK4 and p53, are common in both COPD airway cells and lung tumours. Our hypothesis is that these changes vary with COPD severity and, along with the inflammation caused by COPD, promote the onset of lung cancer. To test this hypothesis, we will look at the frequency of PLK4 and p53 alterations in lung tumours in comparison to healthy lung tissue, and investigate whether these changes work together to promote the development of cancer-like traits in lung cell models. We will then determine if these modifications increase the rate of DNA damage over time, which could also heighten cancer risk. Finally, we will use gene activity data to identify the prevalence of different types of immune cells in COPD patient airways, and determine if they are associated with COPD severity. Overall, this project will improve our understanding of the factors that put COPD patients at high risk for lung cancer and provide insight into methods of cancer prevention. It will also expand our knowledge of the role that immune cells play in cancer onset and may contribute to improvements in immunotherapy."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cohn, David
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~